Levocetirizine Dihydrochloride Tablet, Film Coated
Product Images NDC 10135-639

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 10135-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure For Levocetirizine Dihydrochloride, The Active Component Of Levocetirizine Dihydrochloride Tablets Usp, Is An Orally Active H 1-receptor Antagonist. The Chemical Name Is (r)-[2-[4-[(4-chlorophenyl) Phenylmethyl]-1-piperazinyl] Ethoxy] Acetic Acid Dihydrochloride. Levocetirizine Dihydrochloride Is The R Enantiomer Of Cetirizine Hydrochloride, A Racemic Compound With Antihistaminic Properties. The Molecular Formula Of Levocetirizine Dihydrochloride Is C 21h 25cln 2o 3•2hcl. (Levocetirizine 01)

FDA Label Image

Principal Display Panelndc 10135-0639-30levocetirizine Dihydrochloride Tablets, Usp5 mg30 Tabletsrx Only (Levocetirizine 02)

Principal Display Panelndc 10135-0639-30levocetirizine Dihydrochloride Tablets, Usp5 mg30 Tabletsrx Only (Levocetirizine 02)
This is a medication with the NDC code 10135-0639-30. Each tablet contains Levocetirizine Dihydrochloride USP 5mg. The recommended storage temperature is between 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). The package insert should be consulted for proper dosage information. Pharmacies should dispense this medication in a tight, light-resistant container with a child-resistant closure. This medication's manufacturer is Marlex Pharmaceuticals, Inc.*
FDA Label Image

Principal Display Panelndc 10135-0639-90levocetirizine Dihydrochloride Tablets, Usp5 mg90 Tabletsrx Only (Levocetirizine 03)

Principal Display Panelndc 10135-0639-90levocetirizine Dihydrochloride Tablets, Usp5 mg90 Tabletsrx Only (Levocetirizine 03)
This is a medication with the National Drug Code 10135-0639-90. It contains Levocetirizine Dihydrochloride, USP at a concentration of 5mg per tablet. The typical dosage of this medication should be consulted on the package insert. The pharmacist should dispense this medication in a container that is airtight and has a child-resistant closure. The medication should be stored at a temperature between 20° and 25°C (68° and 77°F), with allowed excursions between 15-30°C (59-86°F) according to USP Controlled Tablets, USP Room Temperature. This medication is produced by Marlex Pharmaceuticals, Inc. in New Castle, DE and contains 90 tablets per package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.